|
Sunday, 08/01/2010
|
Better Learning About the MTD in Phase I Oncology Trial: A Case Study Implementing Bayesian Design Based on Continuous Reassessment Method
Inna Perevozskaya, Pfizer Inc.
2:25 PM
|
Application of Partial Order to Stream Channel Assessment and Bridge Infrastructure Management
Jessica T. Newlin, Bucknell University; Ganapati P. Patil, Penn State
2:35 PM
|
The Philosophy and Intent of Stability Shelf Life
David Christopher, Merck & Co., Inc.
3:05 PM
|
Evaluation of Dose-Finding Designs: On the Interplay Between Theory and Simulation
Assaf P. Oron, University of Washington; Peter Hoff, University of Washington
3:05 PM
|
Statistical Modeling of Tumor Regrowth and the Assessment of Drugs Synergy in Animal Experiments
Eugene Demidenko, Dartmouth Medical School
4:05 PM
|
Benchmark Dose Analysis from Multiple Data Sets: The Cumulative Risk Assessment for N-Methyl Carbamate Pesticides
Rhyne Woodrow Setzer, U.S. Environmental Protection Agency
4:05 PM
|
Value-Added Assessment Models with Continuous and Categorical Responses
Sharon Lohr, Arizona State University; Jennifer Broatch, Arizona State University
4:05 PM
|
Assessment of Drug Effects in Xenograft Models Using Constrained Parametric Maximum Likelihood Estimations
Hong-Bin Fang, University of Maryland Greenebaum Cancer Center
4:25 PM
|
Assessment of Exact Patient Year Method for Clinical Outcome in Drug-Eluting Stent Trials
Peter Lam, Boston Scientific Corporation; Heather Bai, Boston Scientific Corporation; Jian Huang, Boston Scientific Corporation; Hong Wang, Boston Scientific Corporation
4:45 PM
|
Updated Risk Assessment of Variant Creutzfeldt-Jakob Disease (vCJD) Risks for Recipients of Blood and Plasma-Derived Products in the United States
Steven Anderson, FDA; Hong Yang, FDA; Richard Forshee, FDA; Mark Walderhaug, FDA
4:50 PM
|
Different Approaches to Model Averaging in Environmental Risk Assessment
Esben Budtz-Jørgensen, University of Copenhagen
5:20 PM
|
|
Monday, 08/02/2010
|
Effective Use of Online Homework/Grading Assessment Systems
Michael Posner, Villanova University
|
A Review of Existing Audience Response Systems (Clicker) Technology for Formative Assessment in Introductory Statistics
Josh Bernhard, Iowa State University; Amy Froelich, Iowa State University; Ulrike Genschel, Iowa State University
|
Applications of the Truncated Robust Distance (TRD) Method on Large Aggregated Clinical Lab Data for Safety Monitoring and Assessment
Daniel Parks, GlaxoSmithKline; Xiwu Lin, GlaxoSmithKline; Lei Zhu, GlaxoSmithKline; Jie Cheng, GlaxoSmithKline; Kwan Lee, GlaxoSmithKline
|
Comparisons of Methods in Phase I Dose-Escalation Clinical Trial Designs
Liping Huang, Bayer HealthCare Pharmaceuticals
|
Risk Analysis in a Multivariate World
Xunguo Lin, CSIRO; Simon Christopher Barry, CSIRO; Vijay Satyal, Oregon Department of Energy
8:35 AM
|
Futility Assessment Utilizing Conditional Power in a Phase III Clinical Trial
Yan Sun, Amgen Inc.
8:35 AM
|
Time-Variant Response Patterns and Modeling Precise Assessment Time in Confirmatory Clinical Trials
Yoko Tanaka, University of Pittsburgh Graduate School of Public Health
8:50 AM
|
Assessment of Treatment Effect When Data Are Skewed and with Many Zeros
Yue Wang, Astellas Pharma US
10:35 AM
|
Program Assessment and Accreditation, with Particular Reference to Business Schools
J. Keith Ord, Georgetown University; Robert Carver, Stonehill College; Amy Phelps, Duquesne University
10:35 AM
|
Hierarchical Model Building, Fitting, and Checking: A Behind-the-Scenes Look at a Bayesian Analysis of Arsenic Exposure Pathways
Peter F. Craigmile, The Ohio State University; Catherine Calder, The Ohio State University; Hongfei Li, IBM T.J. Watson Research Center; Rajib Paul, Western Michigan University; Noel A. Cressie, The Ohio State University
11:05 AM
|
Modeling Mood Variation Associated with Smoking Using a Mixed-Effects Location Scale Model for Analysis of Ecological Momentary Assessment (EMA) Data
Donald Hedeker, University of Illinois at Chicago; Robin Mermelstein, University of Illinois at Chicago
2:05 PM
|
An Assessment of Imputation Methods for the USDA's Agricultural Resource Management Survey
Sujit Kumar Ghosh, North Carolina State University; Barry Goodwin, North Carolina State University; Joshua D. Habiger, National Agricultural Statistics Service/National Institute of Statistical Sciences; Timothy Paul Keller, National Agricultural Statistics Service; Darcy Miller, National Agricultural Statistics Service; Michael Robbins, National Institute of Statistical Sciences; Kirk White, National Agricultural Statistics Service
2:45 PM
|
Design and Analysis of Discrete-Time Survival Studies with Pooled Biomarker Assessment
Paramita Saha, National Institute of Environmental Health Sciences; Clarice R. Weinberg, National Institute of Environmental Health Sciences
2:45 PM
|
|
Tuesday, 08/03/2010
|
A Second Course of Applied Statistics for Accredited Professional Schools
Amy Phelps, Duquesne University
|
Development and Psychometric Evaluation of the PROMIS(R) Item Banks and Short-Form Instruments
Laura Lee Johnson, National Institutes of Health
|
Using Statistical Concepts to Determine Risk Level of Randomized Clinical Trials That Compare Two Noninvestigational Therapies
Martin L. Lesser, Feinstein Institute for Medical Research; Nina E. Kohn, Feinstein Institute for Medical Research
|
An Assessment of Quality of Life Among Breast Cancer Survivors in Punjab Using Ordinal Regression
Shahid Kamal, University of the Punjab; Ghausia Masood Gilani, University of the Punjab; Rehan Ahmad Khan, University of the Punjab; Afza Rasul, University of the Punjab
9:20 AM
|
Learning Outcomes for Undergraduate Statistics Programs
Scott D. Grimshaw, Brigham Young University; Natalie Blades, Brigham Young University; Del T. Scott, Brigham Young University
10:35 AM
|
Real-Time Safety Assessment: A Sponsor's Approach on Tool Development to Facilitate the Assessment
Christy Chuang-Stein, Pfizer Inc.; Craig Hartford, Pfizer Inc.; David M. Jones, Pfizer Inc.; Janice Lamb, Pfizer Inc.
10:55 AM
|
Weight Calibration across Subject-Specific Samples in the National Assessment of Educational Progress
Jennifer Kali, Westat; Tom Krenzke, Westat; Keith Rust, Westat; John Burke, Westat
11:05 AM
|
The Efficacy of Intensive Statistical Programming Courses at the Undergraduate Level
Nicole Lyn Ifill, University of California, Santa Barbara; Dawn Holmes, University of California, Santa Barbara
11:05 AM
|
Assessment of Alternative Weighting Methods for the National Health Interview Survey
David Shaw, University of Maryland; Joe Fred Gonzalez, Jr., National Center for Health Statistics; Meena Khare, National Center for Health Statistics
11:50 AM
|
The Central Limit Theorem in the Journal of Statistics Education
Juana Sanchez, University of California, Los Angeles; Nicolas Christou, University of California, Los Angeles; Ivo Dinov, University of California, Los Angeles
2:05 PM
|
Multiple Frame Sample Design and Estimation for the 2008 National Sample Survey of Registered Nurses - Theory, Implementation, and Assessment
Ralph DiGaetano, Westat; Jim Green, Westat; Jay Clark, Westat; Marshall Fritz, U.S. Department of Health and Human Services
2:05 PM
|
Ask Good Questions
Patricia B. Humphrey, Georgia Southern University; John D. McKenzie, Jr., Babson College; Edward Mansfield, The University of Alabama; Tom Short, John Carroll University
2:05 PM
|
Benchmark Dose Estimation in Environmental Risk Assessment: From Cancer to Genetic Toxicity and Beyond
Walter W. Piegorsch, The University of Arizona
3:20 PM
|
An Innovative Approach to Frame Development for Hard-to-Identify Populations
Tina Mainieri, Survey Sciences Group, LLC; Jeri Mulrow, National Science Foundation; Sam Schildhaus, National Science Foundation; Emilda Rivers, National Science Foundation
3:20 PM
|
|
Wednesday, 08/04/2010
|
Are There Latent Decision Rules in Expert Occupational Exposure Assessments?
David C. Wheeler, National Cancer Institute; Kai Yu, National Cancer Institute; Melissa Friesen, National Cancer Institute
|
Statistical Risk Assessment for Chemical Substances
Koji Kanefuji, The Institute of Statistical Mathematics; Takayuki Fujii, The Institute of Statistical Mathematics; Masayuki Kageyama, The Institute of Statistical Mathematics ; Masashi Gamo, National Institute of Advanced Industrial Science and Technology; Hiroe Tsubaki, The Institute of Statistical Mathematics
|
Bayesian and Frequentist Methods for Provider Profiling Using Risk-Adjusted Assessments of Medical Outcomes
Michael Joseph Racz, Albany College of Pharmacy and Health Sciences; Joseph Sedransk, Case Western Reserve University
8:35 AM
|
Application of Methods for Assessing Risk-Benefit in Clinical Trials
Menghui Chen, Merck & Co., Inc.; Shailaja Suryawanshi, Merck & Co., Inc.
9:05 AM
|
The Value of Personalized, Predictive Risk-Assessment Tools for the Prevention of Chronic Diseases
Edward J. Moler, Tethys Bioscience, Inc.; Louis P. Garrison, University of Washington; Janice Kolberg, Tethys Bioscience, Inc.; Harald Rinde, BioBridge Strategies Switzerland; Sean D. Sullivan, University of Washington
9:35 AM
|
An Assessment of the Effect of Calibration on Nonresponse Bias in the 2008 Agricultural Resource Management Survey Using 2007 Census of Agriculture Data
Morgan Earp, National Agricultural Statistics Service; Jaki McCarthy, National Agricultural Statistics Service; Eric Porter, National Agricultural Statistics Service; Phil Kott, National Agricultural Statistics Service
9:35 AM
|
Assessment of Quantitative Reasoning Across a General Education Curriculum
Stephanie Lopez Cano, The University of Texas at San Antonio; Nandini Kannan, The University of Texas at San Antonio; Ermine Orta, The University of Texas at San Antonio
9:35 AM
|
Coverage Assessment in the 2011 UK Census
Owen Abbott, Office for National Statistics UK; James Brown, Institute of Education
9:50 AM
|
Benefit Risk Assessment Incorporating Time Component
Paulette Ceesay, Merck & Co., Inc.; Richard Entsuah, Merck & Co., Inc.
9:50 AM
|
Taking Serial Correlation Seriously: An Illustration from an Assessment of Temporal Trend of Racial Disparity in Chlamydia Prevalence Among Black and White Women
Lin H. Tian, CDC; Catherine L. Satterwhite, CDC; Jim R. Braxton, CDC; Samuel L. Groseclose, CDC
10:50 AM
|
Bayesian Design for Nonrandomized Phase II Oncology Trials
Yanmei Xu, GlaxoSmithKline; Bingming Yi, GlaxoSmithKline
10:55 AM
|
A Preliminary Assessment of Cultural Variability in Respondent Actions
Timothy Patrick Johnson, Survey Research Laboratory; Young Ik Cho, Survey Research Laboratory; Allyson Holbrook, Survey Research Laboratory
2:25 PM
|
Performance Assessment of 'Gamma Distribution'-Shaped Detection Functions for Aerial Line Transect Surveys of Large Terrestrial Mammals
Joel Howard Reynolds, U.S. Fish and Wildlife Service; Anna-Marie Benson, University of Alaska, Fairbanks
2:25 PM
|
Assessment of normalization methods in microRNA profiling data and evaluation criteria on choosing the "right" methods
Hui Tang, Mayo Clinic; Jin Jen, Mayo Clinic; Riska Shaun, Mayo Clinic; Ping Yang, Mayo Clinic
3:05 PM
|
|
Thursday, 08/05/2010
|
Biomarkers in Clinical Trials in the Development of Biologics and Risk Assessment
Samir Lababidi, FDA
8:50 AM
|
Calibration in the Continual Reassessment Method for Phase I Clinical Trials
Shing M. Lee, Columbia University; Ying Kuen Cheung, Columbia University
8:50 AM
|
Statistical Considerations in Cost-Effectiveness Assessments of New Medicines in Australia
Ian Marschner, Macquarie University
10:35 AM
|
Model Assessment for Space-Time Point Processes Using Super-Thinning
Robert Alan Clements, University of California, Los Angeles; Alejandro Veen, IBM T.J. Watson Research Center; Rick Schoenberg, University of California, Los Angeles
10:50 AM
|
Statistical Assessment of the Time to Stabilization with Gait Fatigue
Carolyn Morgan, Hampton University; Kristin Denise Morgan, College of William and Mary; Morris Herbert Morgan, III, Hampton University; Peter Pidcoe, Virginia Commonwealth University
11:35 AM
|
|